Home › Funds › D. E. Shaw & Co › NTLA
D. E. Shaw & Co position in NTLA
INTELLIA THERAPEUTICS INC · Health Care
Latest position (Q2 2026)6.44M sh
Reported value held$109.02M
Portfolio Weight0.06%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 25.03K | $3.36M | New |
| Q4 2021 | 2.63K | $311.00K | Reduce |
| Q1 2022 | 218.41K | $15.87M | Add |
| Q2 2022 | 426.35K | $22.07M | Add |
| Q3 2022 | 51.57K | $2.89M | Reduce |
| Q4 2022 | 15.15K | $528.65K | Reduce |
| Q2 2024 | 30.00K | $671.40K | New |
| Q3 2024 | 59.18K | $1.22M | Add |
| Q4 2024 | 98.08K | $1.14M | Add |
| Q1 2025 | 67.50K | $479.90K | Reduce |
| Q2 2025 | 824.73K | $7.74M | Add |
| Q3 2025 | 2.23M | $38.48M | Add |
| Q4 2025 | 5.41M | $48.67M | Add |
| Q1 2026 | 5.73M | $73.44M | Add |
| Q2 2026 | 6.44M | $109.02M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NTLA
- ARK Invest 16.88M sh · $285.54M · Q2 2026
- BlackRock Inc 15.41M sh · $260.72M · Q2 2026
- Vanguard Group 13.01M sh · $116.96M · Q4 2025
- Two Sigma Investments 5.24M sh · $88.58M · Q2 2026
- Fidelity Management & Research (FMR) 4.77M sh · $80.76M · Q2 2026
- Geode Capital Management 3.63M sh · $61.45M · Q2 2026
- Arrowstreet Capital 3.28M sh · $55.51M · Q2 2026
- UBS Group AG 2.45M sh · $41.39M · Q2 2026
- Goldman Sachs Group 2.26M sh · $38.31M · Q2 2026
- Morgan Stanley 1.73M sh · $29.30M · Q2 2026
- Renaissance Technologies 1.40M sh · $23.69M · Q2 2026